Who should India’s National Anti-Doping Agency (NADA) be
testing the most during the course of a year?
The obvious answer would be those in the registered testing
pool (RTP).
According to the World Anti-Doping Agency (WADA) definition
the RTP is the pool of “highest priority” athletes who are subject to “focused
in-competition and out-of-competition testing”.
The RTP is aimed at ensuring that anti-doping agencies have
the chance to test top athletes unannounced at a designated place preferred by
the athlete. A one-hour slot has to be provided to the testers for every day of
the year by an athlete where he/she would be available for testing. Failure to
be at the venue or to file the “whereabouts” may attract a sanction depending
on the circumstances.
Doping is not about consuming steroids and other substances
just before competition and hoping that testers would not catch. It is more
about a systematic consumption to ensure that one is not caught even if tested.
If one is taking steroids one will need a “safe period” of a month or two to be
away from testers. It depends on the substance the athlete is taking, the mode
of ingestion and the dosage.
“But wouldn’t he be tested in the competition?” This is a
question often heard in the context of doping suspicions concerning an athlete.
If the athlete is wise enough he would not be caught even if
he is tested. That is the way his doping cycles would have been designed to
avoid detection.
This is where RTP comes in. At least theoretically that is
the idea. Catch the cheat when he or she is building for the competitions
ahead, giving a safe period to avoid turning in a positive test.
WADA wants agencies to carry out more out-of-competition
tests than in-competition. But that often does not happen. Rules require an
anti-doping authority to test its RTP athletes at least three times a year.
That also, it seems, is a tough task, it would seem, at least for NADA India.
In 2018, NADA failed to test out of competition five of the
six individual track and field gold medallists from India in the Asian Games
before the games. It also failed to test ten of the 25 athletes in its RTP
through the course of the year.
The record was better in 2019, but only marginally. This was
not a multi-discipline games year. For athletics, the big meeting was the World
Championships in Doha in September-October. The NADA had enlarged its RTP from 25 in 2018
to 44 athletes by around mid-2019 (exact dates are not known since NADA does
not indicate a date on the changes in its RTP on its website).
As per figures made available by NADA, in athletics it did
not test at least eight of its RTP members up to November 11, 2019. Another 11
RTP athletes were subjected to just one out-of-competition test with a urine
sample. Seven others were tested twice out of competition.
Only ten RTP athletes were put through the stipulated three
out-of-competition tests based on urine samples.
The 10 athletes in the Target Olympic Podium (TOP) scheme
(Neeraj Chopra, Tajinder Toor, Seema Punia, Arpinder Singh, Muhammed Anas, Hima
Das, A. Dharun, Jinson Johnson, M. Sreeshankar and Avinash Sable) were
subjected to a combined total of 15 out-of-competition tests in 2019 (up to Nov
11). Seema and Arpinder were not tested at all out of competition in this
period.
One would have expected NADA to concentrate more on its RTP
athletes in athletics for out-of-competition testing in 2019 following
revelations about inadequacies the previous year. That did not happen.
The test distribution plan (TDP) should have been so devised
as to have a sensible mix of in-competition and out-of-competition testing. That
would have meant spacing out three out-of-competition tests for RTP athletes in
such a way that they would be well away from the in-competition period unless
NADA was testing for erythropoietin (EPO) or growth hormone or similar
substances.
Though the number of RTP-based out-of-competition tests
among top athletes increased in 2019 compared to 2018, NADA’s choice of periods
for such testing defied logic in many cases.
Those in the RTP who were tested out of competition from one
to five days prior to a competition in 2019 included Arokia Rajiv and Muhammed
Anas (400m); Jinson Johnson
(800m/1500m); Hima Das and M. R. Poovamma (400m); Shivpal Singh and Annu Rani (javelin) and
Tajinder Pal Singh Toor (shot put). All these athletes were also tested
‘in-competition’, making it all the more debatable.
If out-of-competition tests just before a competition happened
to be the only ones under the ‘whereabouts’ programme, then the purpose was all
but defeated.
Only ‘non-specified’ substances that include steroids,
metabolic modulators and certain stimulants are prohibited out-of-competition.
Only ‘non-specified’ substances are tested for out-of-competition samples.
In-competition testing will be for the entire list of prohibited substances
though not all samples are subjected to certain tests, EPO for example.
It is rare that an athlete would come into a competition
with steroids within his/her system till a day or five days prior to a
competition. Those who do test positive for steroids in ‘in-competition’
testing might have possibly made a mistake in their intake of drugs so as to be
caught while competing or else the laboratory is so advanced that it can detect
the minutest quantities of metabolites over a longer period of time.
Since all substances are tested for in ‘in-competition’
testing, it becomes almost meaningless to test out of competition, a day or a
few days before, such athletes who are likely to be tested in-competition. The exception can come in the case of
targeted testing for EPO and related substances since the window for detection
of such substances is very limited, often a few days. Generally, endurance
athletes, in any sport are targeted for EPO.
In 2018, NADA managed to test some athletes training abroad,
though all tests were bunched together closer to the Asian Games, making it
almost a formality being gone through. Yet, in terms of deterrence, it was a
good effort away from our shores even if these tests might have been done by
other agencies on behalf of NADA. In 2019, though, there was to be no testing
of track and field athletes abroad. Was
there a cash crunch?
Contrary to what was being given out by the Athletics
Federation of India (AFI), that the World Anti-Doping Agency (WADA) had come 11
times to test Indian athletes in Europe in 2018, it is now confirmed that WADA
went only once. It collected six Indian samples in that single ‘mission’ in
2018 on Indians training in Europe. In all, WADA did 39 out-of-competition
tests in athletics around the world in 2018.
The Athletics Integrity Unit (AIU) of the IAAF (now World
Athletics) did collect a substantial number of urine and blood samples from the
Indians in 2018 including those out-of-competition samples from Doha before the
Asian championships. Exact numbers of visits in Europe are, however, not
available, though AIU confirmed that 88 urine samples were collected from the
Indians in out-of-competition testing outside India in 2018. There were 25
Indian athletes initially at Spala, Poland. Javelin thrower Neeraj Chopra was the lone
Indian athlete in AIU’s RTP through 2019.
NADA’s in-competition and out-of-competition testing in
athletics has rarely taken the logical route. It often misses the first couple
of days of a national championship or else may collect 20 or 30 samples from
40-odd events. With the National Dope-Testing Laboratory (NDTL) under
suspension by WADA, there is an obvious resource crunch that NADA faces in
getting tests done in foreign labs. This should not result in its attempts to
test Olympics-bound athletes this season.
To get some idea about how lop-sided testing had been in
2019 in certain cases in athletics, we have to look at the nine in-competition
tests that the World University Games
sprint champion Dutee Chand went through last season at home while noting that
amazingly she did not undergo a single out-of-competition test by NADA!
Someone like Gajanand Mistry who figures below 15 in Indian
lists for 400m in 2019 was tested three times out of competition while some of
the better-rated quarter millers were not even tested twice.
Of course, it is NADA’s prerogative to choose athletes for
testing as per RTP, performance, intelligence reports etc. Among the other
prominent athletes tested out of competition were: Jisna Mathew and
Saritaben Gayakwad (400m) two each, V.
K. Vismaya (400m) one, K. S. Jeevan and Noah Nirmal Tom (400m) one each, Jithu
Baby and Alex Antony (400m) three each and Vipin Kasana (javelin) one.
Seema Punia, multiple international medal winner in discus,
who is a TOPs beneficiary and RTP athlete, has undergone just one test in two years! Keeping her in
the RTP and at the same time being unable to do any test at all since she is
probably abroad most of the time, is illogical.
NADA has to shed its testing philosophy. Target-testing
should not mean testing an athlete out of competition a day before his event at
a National meet. “We have done enough tests in athletics” should also not mean
NADA can skip the next National championships which may be the final selection
trial for a major global meet. More tests at university level and Khelo India
and Schools Games would go a long way in curbing the doping menace among young
athletes.